A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals
Tahapan Penelitian : Complete
Sponsor:
PT Kalbe Farma
Mitra Pelaksana:
not specified
No Registry
INA-5L15LDW
Tanggal Input Registry : 19-07-2024
| Tracking Information | |
|---|---|
| Tanggal Antisipasi Studi | 01-01-2021 |
| Outcome Primer | not specified |
| Outcome Skunder | |
| Descriptive Information | |
| Judul Penelitian Popular | A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals |
| Judul Penelitian Ilmiah | A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of GX-19N, A COVID-19 Preventive DNA Vaccine in Healthy Individuals |
| Jenis Penelitian | Interventional |
| Intervensi | GX-19N, A COVID-19 Preventive DNA Vaccine |
| Jumlah Subyek Penelitian | 5 |
| Recruitment Information | |
| Eligibility Criteria | Inclusion Criteria: not specifiedExclusion Criteria: not specified |
| Administrative Information | |
| Nomor Persetujuan Etik | not specified |
| Nomor Persetujuan Material Transfer Agreement | Not applicable |
| Nomor Persetujuan Pelaksanaan Uji Klinik | PPUK/PPUB number |
| Other Study ID Numbers | |
| Contact Person | not specified |